Tufts University School of Dental Medicine
Boston, Massachusetts, 02111, United States
NCT Number: NCT06365047
This is a clinical investigation to measure the changes in the oral environment resulting from a 3 month exposure to an arginine containing toothpaste. This study is a double blind, randomized controlled, parallel design. Seventy (70) male and female subjects who meet the inclusion/exclusion criteria will be enrolled in the study. Following oral health evaluations, subjects will be assigned to the treatment schedule and receive their assigned study product.
This study is active but is not currently recruiting participants.
18 year–80 year
All sexes
Interventional
Phase 3
Boston, Massachusetts, 02111, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Investigative
Control
Time frame: 12 weeks
The objective of this clinical research study is to determine if the use of an Arginine containing toothpaste alters the salivary pH of people with xerostomia.
Time frame: 12 weeks
The objective of this clinical research study is to determine if the use of an Arginine containing toothpaste alters the oral microbiome (salivary and whole mouth plaque) of people with xerostomia.
Tufts University
Other
Clinical Investigation to Measure the Changes in the Oral Environment Resulting From a 12 Weeks Exposure to an Arginine Containing Toothpaste
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820711
Head and Neck Cancer, Head and Neck Neoplasms
Madison, Wisconsin, United States
View Trial DetailsNCT06194123
Halitosis, Mouth Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT07394842
Carcinoma, Carcinoma, Squamous Cell
Cairo, Egypt
View Trial DetailsNCT06877546
Arthritis, Arthritis, Rheumatoid
Helsinki, Finland
View Trial Details